DashboardPortfolio'sControlelijstGemeenschapOntdekScreener
NOT FOR DISTRIBUTION

Integrated Research Limited

ASX:IRI Voorraadrapport

Marktkapitalisatie: AU$51.5m

  • Bedrijfsoverzicht
    • Waardering
    • Toekomstige groei
    • Prestaties in het verleden
    • Financiële gezondheid
    • Dividend
  • Beheer
  • Eigendom
  • Andere informatie
  • Aandelencommunity

Integrated Research Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Ian Lowe

Algemeen directeur

AU$753.2k

Totale compensatie

Percentage CEO-salaris71.11%
Dienstverband CEO1.9yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn2.1yrs
Gemiddelde ambtstermijn bestuur2.8yrs

Recente managementupdates

Recent updates

Analyse-artikel • Jul 14

Why Integrated Research Limited (ASX:IRI) Could Be Worth Watching

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it saw a decent share price growth of 11...
User avatar
Narratiefupdate • Jun 25

IRI: New AI Observability Offerings Will Support Future Upside

Analysts have kept their A$0.36 price target for Integrated Research unchanged, citing only very small adjustments to inputs such as the discount rate, long run revenue growth, profit margin and future P/E assumptions. What’s in the News for Integrated Research Integrated Research announced Iris for Card Payments, an AI powered assistant built on the Prognosis observability platform that uses natural language prompts to provide real time card payments insights.
User avatar
Narratiefupdate • Jun 08

IRI: Product Vision Day And Steady Assumptions Will Support Future Upside

Analysts have reiterated an A$0.36 fair value for Integrated Research, with only minor tweaks to the discount rate, revenue growth, profit margin and forward P/E assumptions. This signals that their updated modelling leaves the overall valuation view broadly intact.
User avatar
Narratiefupdate • May 24

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have maintained their A$0.36 price target for Integrated Research, noting that only minor adjustments to the discount rate, revenue growth, profit margin and forward P/E assumptions were made and that these did not materially change their valuation view. What's in the News Integrated Research scheduled an Analyst and Investor Day focused on outlining its product vision and innovation strategy (Key Developments).
User avatar
Narratiefupdate • Apr 20

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have kept their fair value estimate for Integrated Research steady at A$0.36. Only small technical adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions informed the updated price target stance.
User avatar
Narratiefupdate • Apr 05

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have kept the A$ price target for Integrated Research broadly unchanged, with only a marginal adjustment that reflects slightly updated assumptions for discount rate, revenue growth, profit margins and future P/E multiples. What's in the News Integrated Research has scheduled an Analyst/Investor Day focused on outlining its product vision for the business.
User avatar
Narratiefupdate • Mar 22

IRI: Steady Assumptions And Product Vision Update Will Support Long Term Upside

Analysts have kept the price target for Integrated Research steady at A$0.36, citing only minor tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major shift in the outlook. What's in the News Integrated Research has scheduled an Analyst and Investor Day, giving you a chance to hear directly from management about the business and its direction (company event filing).
User avatar
Narratiefupdate • Mar 08

IRI: Revised Margins And P/E Assumptions Will Support Long Term Upside

Analysts have trimmed their fair value estimate for Integrated Research from A$0.40 to A$0.36. This reflects updated assumptions that pair a slightly higher discount rate and future P/E multiple with more cautious profit margin expectations and revised revenue growth forecasts.
User avatar
Narratiefupdate • Feb 21

IRI: New AI Observability Capabilities Will Support Long Term Upside Potential

Analysts have slightly trimmed their price target for Integrated Research to A$0.40, reflecting small updates to discount rate assumptions and expected future P/E, while keeping fair value and key operating assumptions broadly unchanged. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer for multi vendor unified communications and collaboration observability, built on the company’s Prognosis platform.
User avatar
Narratiefupdate • Feb 06

IRI: New AI Observability Platform Will Support Long Term Upside

Analysts have adjusted their price target for Integrated Research to account for a slightly higher discount rate and a modestly revised future P/E expectation, resulting in a small change in estimated valuation levels. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer for multi vendor unified communications and collaboration observability, built on the company’s Prognosis platform and designed to turn complex monitoring data into plain language answers for IT teams and business users.
Analyse-artikel • Feb 06

Is Now The Time To Look At Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a decent share price growth...
User avatar
Narratiefupdate • Jan 23

IRI: New AI Observability Layer Will Support Long Term Upside

Analysts have made only a marginal adjustment to their price target for Integrated Research, reflecting slightly updated views on discount rates, long term revenue growth, profit margins, and the future P/E multiple, while keeping their fair value estimate broadly in line with prior assumptions. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer embedded in its Prognosis platform, designed to turn complex observability data from unified communications and collaboration environments into plain language insights for IT and business users.
User avatar
Narratiefupdate • Jan 08

IRI: Cloud Observability Services And AI Features Will Support Long Term Upside

Analysts have kept their fair value estimate for Integrated Research broadly steady, making only minor tweaks to inputs such as discount rate, revenue growth, profit margin and future P/E. These changes feed into a small adjustment in the overall price target and reflect a largely unchanged view of the company’s medium term risk and earnings profile.
User avatar
Narratiefupdate • Dec 17

IRI: Cloud Observability Expansion Is Expected To Support Long Term Upside

Analysts have modestly raised their integrated research price target, citing incremental adjustments to discount rate assumptions and forward valuation multiples that support a fair value estimate now framed around improved long term earnings visibility. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer embedded in its Prognosis observability platform.
User avatar
Narratiefupdate • Dec 02

IRI: New Cloud Platform Launch Is Expected To Drive Future Upside

Analysts have slightly reduced their price target for Integrated Research, reflecting minor adjustments in discount rate and future price-to-earnings assumptions. Key financial projections remain essentially unchanged.
User avatar
Narratiefupdate • Nov 18

IRI: Revenue Setbacks Will Be Outweighed By New Platform Launch

Analysts have revised their price target for Integrated Research downward from $0.55 to $0.40. They cite lowered revenue growth projections and compressed profit margins as the primary factors behind the adjustment.
Analyse-artikel • Nov 14

Integrated Research Limited's (ASX:IRI) Prospects Need A Boost To Lift Shares

Integrated Research Limited's ( ASX:IRI ) price-to-earnings (or "P/E") ratio of 4.1x might make it look like a strong...
Analyse-artikel • Aug 30

Integrated Research (ASX:IRI) Is Paying Out A Dividend Of A$0.02

The board of Integrated Research Limited ( ASX:IRI ) has announced that it will pay a dividend on the 21st of October...
User avatar
Narratiefupdate • Aug 27

Revenue May Stabilize While Profit Margins Decline In The Coming Years

Despite a notable increase in consensus revenue growth forecasts, a sharp decline in the future P/E multiple has driven the consensus analyst price target for Integrated Research down from A$0.70 to A$0.55. What's in the News Integrated Research previewed enhanced Cisco cloud migration solutions at Cisco Live, offering deeper visibility, real-time and intelligent insights.
Analyse-artikel • Aug 11

Some Investors May Be Worried About Integrated Research's (ASX:IRI) Returns On Capital

ASX:IRI 1 Year Share Price vs Fair Value Explore Integrated Research's Fair Values from the Community and select yours...
Analyse-artikel • Jun 16

When Should You Buy Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a double-digit share price...
Analyse-artikel • May 09

Integrated Research Limited (ASX:IRI) Shares Fly 29% But Investors Aren't Buying For Growth

Integrated Research Limited ( ASX:IRI ) shareholders would be excited to see that the share price has had a great...
User avatar
Nieuw narratief • Feb 09

Shifting To High-Value Clients And Launching IR Labs May Improve Stability, But Challenges Remain

Strategic focus on high-value enterprise customers and efficient cost management is expected to enhance net margins and revenue stability.
Analyse-artikel • Oct 22

Why Integrated Research Limited (ASX:IRI) Could Be Worth Watching

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it saw a decent share price growth of 17...
Analyse-artikel • Aug 29

Impressive Earnings May Not Tell The Whole Story For Integrated Research (ASX:IRI)

Last week's profit announcement from Integrated Research Limited ( ASX:IRI ) was underwhelming for investors, despite...
Analyse-artikel • Aug 21

Investors Don't See Light At End Of Integrated Research Limited's (ASX:IRI) Tunnel And Push Stock Down 37%

Integrated Research Limited ( ASX:IRI ) shares have had a horrible month, losing 37% after a relatively good period...
Analyse-artikel • Jun 28

Integrated Research Limited (ASX:IRI) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Despite an already strong run, Integrated Research Limited ( ASX:IRI ) shares have been powering on, with a gain of 33...
Analyse-artikel • Jun 11

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...
Analyse-artikel • Apr 20

Why Investors Shouldn't Be Surprised By Integrated Research Limited's (ASX:IRI) Low P/S

Integrated Research Limited's ( ASX:IRI ) price-to-sales (or "P/S") ratio of 0.8x might make it look like a buy right...
Analyse-artikel • Mar 02

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Analyse-artikel • Dec 27

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a decent share price growth...
Analyse-artikel • Nov 21

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Key Insights Using the Dividend Discount Model, Integrated Research fair value estimate is AU$0.30 Integrated...
Analyse-artikel • Aug 28

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

While Integrated Research Limited ( ASX:IRI ) might not be the most widely known stock at the moment, it received a lot...
Analyse-artikel • May 12

What Is Integrated Research Limited's (ASX:IRI) Share Price Doing?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it received a lot of attention from...
Analyse-artikel • Jan 11

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it received a lot of attention from a...
Analyse-artikel • Nov 24

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Today we will run through one way of estimating the intrinsic value of Integrated Research Limited ( ASX:IRI ) by...

Analyse CEO-vergoeding

Hoe is Ian Lowe's beloning veranderd ten opzichte van Integrated Research's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2026AU$753kAU$536k

AU$1m

Mar 31 2026n/an/a

AU$4m

Dec 31 2025n/an/a

AU$7m

Sep 30 2025n/an/a

AU$10m

Jun 30 2025AU$639kAU$385k

AU$13m

Compensatie versus markt: De totale vergoeding ($USD 540.25K ) Ian } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 339.91K ).

Compensatie versus inkomsten: De vergoeding van Ian is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Ian Lowe (56 yo)

1.9yrs
Tenure
AU$753,158
Compensatie

Mr. Ian Lowe, ASCM, is Chief Executive Officer of Integrated Research Limited from October 1, 2024 and also serves as its Director since October 17, 2024 and serves as its Managing Director since 2024. Mr....


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Ian Lowe
CEO, MD & Director1.9yrsAU$753.16kgeen gegevens
Christian Shaw
Chief Financial Officer2.5yrsAU$557.99kgeen gegevens
Michael Tomkins
Chief Technology Officer7yrsgeen gegevensgeen gegevens
Gemma Garkut
Head of Communications & IRno datageen gegevensgeen gegevens
Marco Cantamessi
Senior Vice President of Global Sales2.1yrsgeen gegevensgeen gegevens
Geoff Sieron
Senior Vice President of IR Labs2.1yrsgeen gegevensgeen gegevens
Elie Shuggi
Chief Product Officer1.7yrsgeen gegevensgeen gegevens
Leanne Ralph
Company Secretary1.8yrsgeen gegevensgeen gegevens
2.1yrs
Gemiddelde duur

Ervaren management: Het managementteam van IRI wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.1 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Ian Lowe
CEO, MD & Director1.9yrsAU$753.16kgeen gegevens
Mark Ronald Brayan
Independent Non-Executive Director2.8yrsAU$103.00k0.14%
A$ 74.1k
Peter Lloyd
Independent Non-Executive Chairman16.2yrsAU$185.40kgeen gegevens
Katherine Greenhill
Independent Non-Executive Director2.4yrsAU$103.00k0.050%
A$ 25.7k
Michael Hitz
Independent Non-Executive Director2.9yrsAU$103.00k0.17%
A$ 85.5k
2.8yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van IRI wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.8 jaar), wat duidt op een nieuw bestuur.


Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/09/12 00:03
Aandelenkoers aan het einde van de dag2026/09/10 00:00
Inkomsten2026/06/30
Jaarlijkse inkomsten2026/06/30

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
  • SEC-formulier 10-K
  • SEC-formulier 10-Q
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
  • Onderzoeksrapporten van analisten
  • Blue Matrix
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
  • ICE Marktgegevens
  • SEC-formulier S-1
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
  • SEC-formulier 4
  • SEC-formulier 13D
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
  • SEC-formulier 10-K
  • SEC-formulier DEF 14A
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen
  • SEC-formulier 8-K

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Integrated Research Limited wordt gevolgd door 4 analisten. 1 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Chris SavageBell Potter
Katie BelleLodge Partners Pty Ltd.
Todd GuyotMA Moelis Australia Securities Pty Ltd

Neem overal betere beleggingsbeslissingen

Scan om te downloaden
Open App StoreGoogle Play openen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Gegevensbronnen bekijken
Markten
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Beleggingsideeën
  • Ondergewaardeerde bedrijven
  • Dividendkrachtpatsers
  • Kopen met voorkennis
  • Kernenergie
  • Autonome voertuigen
  • Kunstmatige intelligentie
  • Crypto en blockchain
  • Cyberbeveiliging
  • Meer ideeën
Voorraad Gemeenschappen
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Functies en gereedschappen
  • Portfolio Volger
  • Aandelen screener & waarschuwingen
  • Diverse en eerlijke waarden
  • Dividend berekenen
Nieuws & Ontdekkingen
  • Laatste voorraadnieuws
  • Globale markt Inzichten
  • De Foxhole
  • Beleggingsideeën
  • Community nominale waarden
  • Nieuw
Simply Wall St
  • Plannen en prijzen
  • Adverteren
  • Over ons
  • Neem contact met ons op
  • Carrière
  • Helpcentrum
  • Leren beleggen in aandelen
  • Affiliate programma
  • Bedrijf & Onderneming
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Algemene voorwaarden
  • Privacybeleid
  • AI-voorwaarden
  • Gids voor financiële diensten